PAYX
47
6
AAL
41
2
HP
33
4
ABBV
59
2
SRCL
40
6
SPG
55
5
MDT
60
4
SWKS
42
5
GWW
48
4
ZION
59
4
ZTS
47
-16
INTU
69
4
ROK
43
4
HD
35
4
GOOG
91
2
GPC
56
2
TSCO
56
6
SYK
42
-13
DRI
57
3
ADSK
52
4
PAYX
47
6
AAL
41
2
HP
33
4
ABBV
59
2
SRCL
40
6
SPG
55
5
MDT
60
4
SWKS
42
5
GWW
48
4
ZION
59
4
ZTS
47
-16
INTU
69
4
ROK
43
4
HD
35
4
GOOG
91
2
GPC
56
2
TSCO
56
6
SYK
42
-13
DRI
57
3
ADSK
52
4
Financhill
Back

Autolus Therapeutics PLC 10K Form

Buy
69

AUTL
Autolus Therapeutics PLC

Last Price:
4.19
Seasonality Move:
9.81%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AUTL News And Ratings

See the #1 stock for the next 7 days that we like better than AUTL

AUTL Financial Statistics

Sales & Book Value

Annual Sales: $1.7M
Cash Flow: $-26.31M
Price / Cash Flow: 0
Annual Sales: $0.64
Price / Book: 10

Profitability

EPS (TTM): -1.20000
Net Income (TTM): $-208.38M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Autolus Therapeutics PLC Earnings Forecast

Key Autolus Therapeutics PLC Financial Ratios

  • The Research & Development expenses have been 7,684.39% of Revenue.
  • The Interest Expense is -21.63% of Operating Income.
  • The Net Earning history of AUTL is -12,272.26% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 5 years.

Autolus Therapeutics PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: AUTL
CUSIP: 05280R
Website: autolus.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AUTL Technical Analysis vs Fundamental Analysis

Buy
69
Autolus Therapeutics PLC (AUTL) is a Buy

Is Autolus Therapeutics PLC a Buy or a Sell?